Users Online: 59

Home Print this page Email this page Small font sizeDefault font sizeIncrease font size

Home | About us | Editorial board | Search | Ahead of print | Current issue | Archives | Submit article | Instructions | Subscribe | Contacts | Login 
 Back To Article

  Reader Comments

Year : 2022 | Volume:  12 | Issue Number:  3


The Risk of COVID-19 in Patients of Chronic Kidney Disease with Cognitive Dysfunction Like Alzheimer Disease: A Perspective on Erythropoietin as a Potential Adjuvant Therapy

Ganesan Vinothkumar, Nehru Mohanraj, Shankar Geethamalini, Prabhu Venkataraman

Add Your Comments
No one has added comments on this article. Click here to add your remarks